Pediatric HIV-1 in Kenya: Pattern and correlates of viral load and association with mortality

Journal of Acquired Immune Deficiency Syndromes

Volumn 51, Issue 2, 2009, Pages 209-215

  Obimbo, Elizabeth Maleche ^a   Wamalwa, Dalton ^a   Richardson, Barbra ^b,c   Mbori Ngacha, Dorothy ^a   Overbaugh, Julie ^c   Emery, Sandra ^c   Otieno, Phelgona ^a   Farquhar, Carey ^b   Bosire, Rose ^a   Payne, Barbara Lohman ^a,b   John Stewart, Grace ^a,b,d  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b UNIVERSITY OF WASHINGTON   (United States)

^c USA   (United States)

^d Box 359909 ^*  (United States)

Author keywords

HIV 1; Mortality; Pathogenesis; Pediatric; Timing of HIV 1 infection; Viral load

Indexed keywords

VIRUS RNA;

ARTICLE; FEMALE; GESTATION PERIOD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTHER FETUS RELATIONSHIP; NEWBORN; PRIORITY JOURNAL; VIRUS LOAD; ADOLESCENT; ADULT; COHORT ANALYSIS; DISEASE TRANSMISSION; KENYA; PREGNANCY; PROSPECTIVE STUDY; RISK FACTOR; VIROLOGY;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KENYA; MALE; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 67649226460     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31819c16d8     Document Type: Article

References (28)

1. Richardson BA, Mbori-Ngacha D, Lavreys L, et al. Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection. J Virol. 2003;77:7120-7123.
2. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med. 1997; 336:1337-1342.
3. Mofenson LM, Korelitz J, Meyer WA III, et al. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. J Infect Dis. 1997;175:1029-1038.
4. Dickover RE, Dillon M, Leung KM, et al. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis. 1998; 178:375-387.
5. Kalish LA, McIntosh K, Read JS, et al. Evaluation of human immunodeficiency virus (HIV) type 1 load, CD4 T cell level, and clinical class as time-fixed and time-varying markers of disease progression in HIV-1-infected children. J Infect Dis. 1999;180:1514-1520.
6. Rich KC, Fowler MG, Mofenson LM, et al. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group. Pediatrics. 2000;105:e8.
7. Kaufmann GR, Cunningham P, Zaunders J, et al. Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection. Sydney Primary HIV Infection Study Group. J Acquir Immune Defic Syndr. 1999;22: 437-444.
8. Engels EA, Rosenberg PS, Katki H, et al. Trends in human immunodeficiency virus type 1 (HIV-1) load among HIV-1-infected children with hemophilia. J Infect Dis. 2001; 184:364-368.
9. Biggar RJ, Janes M, Pilon R, et al. Virus levels in untreated African infants infected with human immunodeficiency virus type 1. J Infect Dis. 1999; 180:1838-1843.
10. Obimbo EM, Mbori-Ngacha DA, Ochieng JO, et al. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatr Infect Dis J. 2004;23:536-543.
11. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999;353:773-780.
12. Panteleeff DD, John G, Nduati R, et al. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol. 1999;37:350-353.
13. Emery S, Bodrug S, Richardson BA, et al. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol. 2000;38:2688-2695.
14. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
15. Mbori-Ngacha D, Nduati R, John G, et al. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA. 2001;286:2413-2420.
16. Sandberg JK, Fast NM, Jordan KA, et al. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol. 2003;170:4403-4410.
17. Lohman BL, Slyker JA, Richardson BA, et al. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J Virol. 2005;79:8121-8130.
18. Velilla PA, Rugeles MT, Chougnet CA. Defective antigen-presenting cell function in human neonates. Clin Immunol. 2006;121:251-259.
19. Vekemans J, Ota MO, Wang EC, et al. T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol. 2002;127:495-498.
20. Adkins B. Neonatal T cell function. J Pediatr Gastroenterol Nutr. 2005; 40 (Suppl 1):S5-S7.
21. Legrand FA, Nixon DF, Loo CP, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE. 2006;1:e102.
22. Rouet F, Sakarovitch C, Msellati P, et al. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics. 2003; 112:e289.
23. Biggar RJ, Broadhead R, Janes M, et al. Viral levels in newborn African infants undergoing primary HIV-1 infection. AIDS. 2001;15:1311-1313.
24. Newell ML, Gray L, Thorne C, Cortina-Borja MC, Peckham C. Level and pattern of HIV-1-RNA viral load over age: differences between girls and boys? AIDS. 2002;16:97-104.
25. Napravnik S, Poole C, Thomas JC, et al. Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr. 2002;31:11-19.
26. The Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004; 189:2154-2166.
27. Ioannidis JP, Tatsioni A, Abrams EJ, et al. Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS. 2004; 18:99-108.
28. Kimata JT, Kuller L, Anderson DB, et al. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med. 1999;5:535-541.